GlobeImmune is a biopharmaceutical company developing targeted molecular immunogens (Tarmogens) for the treatment of cancer and infectious diseases. Initial Public Offering (NASDAQ: GBIM) in July 2014
GlobeImmune is a biopharmaceutical company developing targeted molecular immunogens (Tarmogens) for the treatment of cancer and infectious diseases. Initial Public Offering (NASDAQ: GBIM) in July 2014